Empery Asset Management LP 13D and 13G filings for Titan Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-24 10:35 am Sale |
2021-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP |
Empery Asset Management LP | 43,022 4.990% |
-4,206 (-8.91%) |
Filing |
| 2021-01-21 2:28 pm Purchase |
2021-01-15 | 13G | Titan Pharmaceuticals, Inc. TTNP |
Empery Asset Management LP | 47,229 6.910% |
47,229 (New Position) |
Filing |